When bringing a life sciences product to market, the entire healthcare and regulatory ecosystem – including healthcare providers, patients, caregivers, health plans, regulators, advocates and more – needs to be taken into consideration to better alleviate the fear, uncertainty and doubt caused by the myriad of market dynamics facing the industry.
At Baker Tilly, our team of commercial enablement professionals understand the criticality for life science companies to plan for – and adopt – comprehensive go-to-market strategies. These tools enable organizations to effectively navigate through the pre-commercial assessment, field execution optimization and demand creation stages of a product’s launch program.
Understanding all possible market dynamics and adequately planning for each situation is a critical component to launching a product in today’s complex, disruptive and uncertain healthcare environment. At Baker Tilly, our commercial enablement team can help lead your life science organization through the myriad of situations that can cause a great deal of fear, uncertainty and doubt, including:
As a result, it has become even more imperative for your life science company to effectively plan for all possible contingencies and execute your go-to-market strategies with flexibility in order to adjust to ever-changing dynamics in today’s competitive marketplace.
Baker Tilly works with life science companies to address the market dynamics resulting from a more customer-driven approach to healthcare, including:
With the foundation of Baker Tilly’s unique Product Opportunity Evaluation Model (P.O.E.M.) to validate an asset’s economic value as well as plan for the successful launch of a new life science product, our commercial enablement team can help lead your company through a more linear, iterative building process methodology. Our team is able to:
Our experience includes helping emerging life sciences companies plan for and develop effective go-to-market programs, as well as helping established companies reinvigorate under-performing brands, expand access and utilization with payer and provider organizations, expand customer channels through innovative economic modeling, develop risk-sharing contracting strategies and create value-based dossiers and communications.
Whether the challenge is launching an entirely new product, relaunching an existing product or establishing a new division within the organization, Baker Tilly can help. We'll guide your company through the planning, pre-commercial development and launch of new products, while helping you expand market share and new-customer channels to keep your product brand on track and trending toward expected business performance goals. Our team can also step in to validate economic value potential of an asset in consideration of acquisition, in-licensing or merger.
Due to the amount of complex regulations that are applicable to the life sciences industry, it is imperative to incorporate adequate regulatory planning during the pre-commercial phase of a product. It is also important to have a keen understanding for the existing disease or patient landscape in order to create a process that can be successfully executed and that can establish long-term commercial success.
Baker Tilly’s commercial enablement team can provide help to your company during the pre-commercial assessment phase of a new or existing product, including:
Once the pre-commercial assessment phase has been completed and the program’s foundation has been laid out, planning the design of the execution program and establishing the proper assets to ensure successful deployment is required. Baker Tilly’s commercial enablement team can help your life science company establish and optimize its field execution strategy, including:
To drive market demand and also ensure disciplined adherence to all regulatory compliance requirements with the myriad of customers – providers, health systems, patients, caregivers and health plans – each must be adequately accounted for and addressed according to their needs. Baker Tilly’s life sciences team provides experience for demand creation considerations, including: